Bacterial vaginosis (BV) is an awfully common—and awful—condition that impacts 1/4 to 1/3 of women worldwide in their lifetime. BV is triggered when the vaginal microbiome, which is normally dominated ...
Treating rare diseases can be complicated at the best of times, and it gets even more complicated when different patients with the same disease exhibit different symptoms. Now, researchers from Japan ...
Vaccine efficacy against infection wanes, but does everyone need a 2nd booster? This is a MedPage Today story. As the U.S. experiences a dip in COVID-19 cases and mask mandates are being lifted, some ...
ATLANTA, GA, Sept. 19, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (GOVX), a biotechnology company developing human vaccines and immunotherapies against infectious diseases and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results